Decatur Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,361
Closed -$1.19M 56
2023
Q2
$1.19M Sell
32,361
-458
-1% -$17.8K 0.81% 46
2023
Q1
$1.34M Sell
32,819
-5,926
-15% -$256K 1.01% 35
2022
Q4
$1.99M Buy
38,745
+98
+0.3% +$4.7K 1.43% 25
2022
Q3
$1.69M Sell
38,647
-10
-0% -$486 1.28% 27
2022
Q2
$2.03M Buy
38,657
+25
+0.1% +$1.27K 1.5% 21
2022
Q1
$2M Buy
38,632
+3,807
+11% +$198K 1.16% 26
2021
Q4
$2.06M Sell
34,825
-310
-0.9% -$15.4K 1.22% 26
2021
Q3
$1.51M Sell
35,135
-40,303
-53% -$1.79M 1% 36
2021
Q2
$2.95M Buy
75,438
+191
+0.3% +$7.43K 0.92% 43
2021
Q1
$2.73M Sell
75,247
-66,790
-47% -$2.37M 0.94% 46
2020
Q4
$5.23M Buy
+142,037
New +$5.21M 0.96% 46
2017
Q1
Sell
-374,065
Closed -$11.5M 107
2016
Q4
$11.5M Sell
374,065
-61,606
-14% -$1.88M 1.66% 35
2016
Q3
$14M Buy
435,671
+11,963
+3% +$400K 1.75% 25
2016
Q2
$14.2M Sell
423,708
-17,734
-4% -$566K 1.91% 21
2016
Q1
$12.4M Sell
441,442
-711
-0.2% -$20.3K 1.63% 41
2015
Q4
$13.5M Sell
442,153
-195,227
-31% -$6.14M 1.74% 28
2015
Q3
$19M Buy
+637,380
New +$20.4M 2.59% 8

Other funds holding PFE

Decatur Capital Management's PFE Position: Q3 2023 in Review

Decatur Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 32,361 shares — an estimated $1.19M sold.

Decatur Capital Management first reported a position in PFE in Q3 2015 and held it in 17 quarters. The position peaked at $19M in Q3 2015. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Decatur Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Decatur Capital Management sold 32,361 Pfizer shares in Q3 2023, an estimated $1.19M.
  • Decatur Capital Management first reported a position in Pfizer in Q3 2015 and held it in 17 quarters.
  • Decatur Capital Management's Pfizer position peaked at $19M in Q3 2015.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Decatur Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.